(Q48352293)

10 February 2018

title

Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI. (English)

1 reference

10 February 2018

author name string

Kun Xing

1

1 reference

10 February 2018

Xianghua Fu

2

1 reference

10 February 2018

Yanbo Wang

3

1 reference

10 February 2018

Wei Li

4

1 reference

10 February 2018

Xinshun Gu

5

1 reference

10 February 2018

Guozhen Hao

6

1 reference

10 February 2018

Qing Miao

7

1 reference

10 February 2018

Shiqiang Li

8

1 reference

10 February 2018

Yunfa Jiang

9

1 reference

10 February 2018

Weize Fan

10

1 reference

10 February 2018

Wei Geng

11

1 reference

10 February 2018

publication date

31 January 2015

1 reference

10 February 2018

published in

Heart and Vessels

1 reference

10 February 2018

volume

31

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

490-498

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00380-015-0642-8

exact match

0 references

cites work

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Effect of nesiritide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Contrast-induced nephropathy: a clinical and evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Re-elevation of T-wave from day 2 to day 4 after successful percutaneous coronary intervention predicts chronic cardiac systolic dysfunction in patients with first anterior acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Cardiac tamponade as an independent condition affecting the relationship between the plasma B-type natriuretic peptide levels and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Cystatin C in acute heart failure without advanced renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Contrast-induced nephropathy: definition, epidemiology, and patients at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-015-0642-8

Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects

21 January 2018

1 reference

12 December 2020

Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases

1 reference

12 December 2020

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

12 December 2020

B-type natriuretic peptide in patients with systemic right ventricle

1 reference

12 December 2020

Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes

1 reference

12 December 2020

The effect of acute renal failure on mortality. A cohort analysis

1 reference

12 December 2020

Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.

1 reference

12 December 2020

10.1007/S00380-015-0642-8

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018